Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis

Clinical trial NCT03041025 · COMPLETED

Trial details

NCT number: NCT03041025
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Scleroderma, Systemic

Start date: 2017-06-05
Primary completion: 2020-07-07
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.